Your browser doesn't support javascript.
loading
Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women.
Moniz, Michelle H; Soliman, Ann B; Kolenic, Giselle E; Tilea, Anca; Fendrick, A Mark; Bell, Sarah; Dalton, Vanessa K.
Afiliação
  • Moniz MH; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan; University of Michigan Institute of Healthcare Policy and Innovation, Ann Arbor, Michigan. Electronic address: mmoniz@med.umich.edu.
  • Soliman AB; University of Michigan Medical School, Ann Arbor, Michigan.
  • Kolenic GE; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.
  • Tilea A; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.
  • Fendrick AM; Department of Internal Medicine, University of Michigan Department of Internal Medicine, Ann Arbor, Michigan; University of Michigan School of Public Health, Ann Arbor, Michigan; University of Michigan Center for Value-Based Insurance Design, Ann Arbor, Michigan.
  • Bell S; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.
  • Dalton VK; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan; University of Michigan Institute of Healthcare Policy and Innovation, Ann Arbor, Michigan.
Womens Health Issues ; 29(6): 465-470, 2019.
Article em En | MEDLINE | ID: mdl-31495642
ABSTRACT

BACKGROUND:

Cost sharing may impede postpartum contraceptive use. We evaluated the association between out-of-pocket costs and long-acting reversible contraceptive (LARC) insertion among commercially insured postpartum women.

METHODS:

Using the Clinformatics Data Mart, we examined out-of-pocket costs for LARC insertions at 0 to 3 and 4-60 days postpartum among women in employer-sponsored health plans from 2013 to 2016. Patient costs were estimated by summing copayment, coinsurance, and deductible payments for LARC services (device + placement). Multivariable logistic regression evaluated the association between plan cost sharing for LARC services (at least one beneficiary with >$200 cost share) and LARC insertion by 60 days postpartum (yes/no).

RESULTS:

We identified 396,073 deliveries among women in 51,797 employer-based plans. Overall, LARC placement by 60 days postpartum was observed after 5.2% (n = 20,604) of deliveries. Inpatient LARC insertion (n = 233; 0.06% of deliveries) was less common than outpatient LARC insertion (n = 20,375; 5.14% of deliveries). Cost sharing was observed in 23.4% of LARC insertions (inpatient IUD median, $50.00; range, $0.93-5,055.91; inpatient implant median, $11.91; range, $2.49-650.14; outpatient IUD median, $25.00; range, $0.01-3,354.80; outpatient implant median, $27.20; range, $0.18-2,444.01). Among 5,895 plans with at least one LARC insertion and after adjusting for patient age, poverty status, race/ethnicity, region, and plan type, women in plans with cost sharing of more than $200 demonstrated lower odds of LARC use by 60 days postpartum (odds ratio, 0.74; 95% confidence interval, 0.71-0.77).

CONCLUSIONS:

Cost sharing for postpartum LARC is associated with use, suggesting that out-of-pocket costs may impede LARC access for some commercially insured postpartum women. Reducing out-of-pocket costs for the most effective forms of contraception may increase use.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custo Compartilhado de Seguro / Comportamento Contraceptivo / Contracepção Reversível de Longo Prazo / Seguro Saúde / Dispositivos Intrauterinos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custo Compartilhado de Seguro / Comportamento Contraceptivo / Contracepção Reversível de Longo Prazo / Seguro Saúde / Dispositivos Intrauterinos Idioma: En Ano de publicação: 2019 Tipo de documento: Article